US House Appropriators Request CBD Enforcement As They Ante Up $5M For FDA's Rule Development
Executive Summary
Appropriation Committee members target $5m for FDA's CBD policy work and suggest the agency enforce against noncompliant firms in their report accompanying legislation proposing the agency’s fiscal 2021 budget.
You may also be interested in...
Temporary Funding For US Agencies Delays $5M For FDA’s Cannabidiols Regulatory Pathway Work
Senate on 29 September was expected to a pass a CR the House passed a week earlier to fund FDA and other federal departments and agencies through 11 December.
With CBD Products Unlawful, FDA Enforcement Policy Guidance Has No Economic Significance
As draft guidance receives OMB review, FDA’s determination of no economic significance reflects its official position that the thousands of supplements, food and personal care products containing CBDs available in the US are unlawful.
Unpublished And Under Review? US FDA’s CBD Policy Draft Guidance Still Has Industry Talking
Supplements containing hemp-derived cannabidiols aren’t typical products subject to FDA’s regulatory oversight, and the document stating its thinking on enforcement in the market submitted to the Office of Management and Budget isn’t a typical draft guidance.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: